Minnesota FOIA #P010262907

Regenerative medicine for the durable remission of HIV: Translationalmedicine for IND-enabling preclinical and manufa...

This purchase order is a contract awarded on September 18, 2024, by the TWIN_CITIES government agency to MARPAM PHARMA for $200,000. The contract covers regenerative medicine research aimed at durable remission of HIV, including IND-enabling preclinical and manufacturing studies. The vendor, MARPAM PHARMA, is located in Oakdale, Minnesota, USA. The award involves a single lot with a quantity of 1, and the procurement appears to be a one-time transaction. The contract emphasizes research and development in the biomedical field, with no specific mention of multi-year or blanket arrangements.

Description

Regenerative medicine for the durable remission of HIV: Translationalmedicine for IND-enabling preclinical and manufacturing studies